MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$35,148K
Unrealized gain (loss) on
investments
$26K
Net loss
attributable to common...
-$35,174K
Interest income
$2,934K
Other income
$1K
Loss from operations
-$38,109K
Total operating
expenses
$38,109K
Research and development
$24,769K
General and
administrative
$13,340K
Back
Back
Income Statement
source: myfinsight.com
AN2 Therapeutics, Inc. (ANTX)
AN2 Therapeutics, Inc. (ANTX)